Answer
Interactions caused by ertapenem inhibiting P-glycoprotein-mediated or CYP-mediated clearance of medicinal products are unlikely.
Sources for this answer
- INVANZ 1g powder for concentrate for solution for infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 28Document updated
Sources checked